Adalat and anaemia Patient Reports February 13, 2012

Adalat Side Effects Report #5035522-6
Adalat side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Female patient, 86 years of age, weighting 104.1 lb, was diagnosed with hypertension, renal failure chronic and was treated with Adalat. After drug was administered, patient experienced the following side effects: anaemia, anuria, ascites, asthma , atrial tachycardia, benign ovarian tumour, blood creatinine increased, blood potassium increased, body mass index increased. Adalat dosage: 10 MG, BID. During the same period patient was treated with SEPAZON, ALLOPURINOL, LASIX, DESFERAL, PURSENNID, CALCIUM POLYSTYRENE SULFONATE. Patient died on 02/18/2006.

Adalat Side Effects Report #5129473-6
Adalat side effect was reported by a Physician from JAPAN on Sept 28, 2006. Male patient, 85 years of age, was diagnosed with hypertension, hyperlipidaemia, hyperuricaemia, benign prostatic hyperplasia, cerebrovascular disorder and was treated with Adalat. After drug was administered, patient experienced the following side effects: amnesia, anaemia, cognitive disorder, duodenal ulcer, intestinal ulcer, melaena. Adalat dosage: TOTAL DAILY DOSE: 160 MG UNIT DOSE: 40 MG. During the same period patient was treated with LIPITOR, URINORM, HARNAL D, HARNAL D, BUFFERIN. Patient was hospitalized. Patient recovered.

Adalat Side Effects Report #4847798-6
Adalat side effect was reported by a Consumer or non-health professional from SWEDEN on Nov 28, 2005. Male patient, 57 years of age, was diagnosed with hypertension and was treated with Adalat. After drug was administered, patient experienced the following side effects: anaemia, coordination abnormal, epistaxis, hypoaesthesia, sensory disturbance. Adalat dosage: 20 MG, TOTAL DAILY, ORAL. During the same period patient was treated with CYKLOKAPRON. Patient was hospitalized. Patient recovered.

Adalat Side Effects Report #4662389-8
Adalat side effect was reported by a Consumer or non-health professional from on May 10, 2005. Male patient, 63 years of age, weighting 136.7 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Adalat. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, cerebral infarction, depressed level of consciousness, faeces discoloured, gastrointestinal haemorrhage, haematoma, malignant neoplasm progression. Adalat dosage: unknown. Patient was hospitalized. Patient died on 05/08/2004.


Adalat Side Effects Report #4677607-X
Adalat side effect was reported by a Consumer or non-health professional from on May 10, 2005. Male patient, 63 years of age, weighting 136.7 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Adalat. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, cerebral infarction, depressed level of consciousness, faeces discoloured, gastrointestinal haemorrhage, haematoma, malignant neoplasm progression. Adalat dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient died on 05/08/2004.

Adalat Side Effects Report #5717432-1
Adalat side effect was reported by a Pharmacist from JAPAN on Apr 17, 2008. Female patient was treated with Adalat. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased. Adalat dosage: TOTAL DAILY DOSE: 20 MG UNIT DOSE: 10 MG. During the same period patient was treated with BIOFERMIN, MUCOSTA, MAGLAX, LAXOBERON. Patient recovered.

Adalat Side Effects Report #5753131-8
Adalat side effect was reported by a Pharmacist from JAPAN on May 23, 2008. Female patient was treated with Adalat. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased. Adalat dosage: TOTAL DAILY DOSE: 20 MG UNIT DOSE: 10 MG. During the same period patient was treated with MUCOSTA, GENTACIN, RASENAZOLIN, KEFPOLIN, LOXONIN, BIOFERMIN, MAGLAX, LAXOBERON. Patient recovered.